Related Experiment Videos
Prostacyclin overproduction in Bartter's syndrome
Lancet (London, England)
|October 13, 1979
Summary
Patients with Bartter's syndrome show increased urinary prostacyclin metabolite excretion. This suggests prostacyclin overproduction contributes to hyper-reninaemia and blood pressure issues in this condition.
Area of Science:
- Nephrology
- Endocrinology
- Cardiovascular Physiology
Background:
- Bartter's syndrome is a rare genetic kidney disorder.
- It is characterized by electrolyte imbalances and hormonal dysregulation.
Purpose of the Study:
- To investigate the role of prostanoids in Bartter's syndrome.
- To compare prostacyclin and thromboxane metabolite excretion in patients and controls.
Main Methods:
- Radioimmunoassays were used to measure urinary 6-keto-prostaglandin F1alpha and thromboxane B2.
- Measurements were performed in five female patients with Bartter's syndrome and five healthy female controls.
Main Results:
- Bartter's syndrome patients excreted significantly higher levels of 6-keto-prostaglandin F1alpha (a prostacyclin metabolite) compared to controls.
- Urinary thromboxane B2 excretion levels were similar between patients and controls.
Conclusions:
- The findings suggest an overproduction of prostacyclin in Bartter's syndrome.
- Prostacyclin overproduction may mediate hyper-reninaemia and impaired blood pressure responsiveness in this condition.